Gemcitabine and disease progression Patient Reports February 11, 2012

Gemcitabine Side Effects Report #5308407-5
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on Apr 20, 2007. Female patient, 61 years of age, weighting 124.8 lb, was diagnosed with t-cell lymphoma refractory and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disease progression, haematocrit decreased, haemoglobin decreased, platelet count decreased. Gemcitabine dosage: 1280 MG DAYS 1 + 8 IV DRIP. During the same period patient was treated with BORTEZOMIB. Patient recovered.

Gemcitabine Side Effects Report #5350419-X
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on June 05, 2007. Female patient, 61 years of age, weighting 127.4 lb, was diagnosed with t-cell lymphoma refractory and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: cough, disease progression, dyspnoea, pneumonia viral, thrombocytopenia. Gemcitabine dosage: 1280 MG DAYS 1 AND 8 IV DRIP. During the same period patient was treated with BORTEZOMIB. Patient was hospitalized. Patient died on 05/18/2007.

Gemcitabine Side Effects Report #5657233-6
Gemcitabine side effect was reported by a Physician from UNITED STATES on Mar 07, 2008. Female patient, weighting 114.6 lb, was diagnosed with squamous cell carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: disease progression, respiratory failure. Gemcitabine dosage: 3000 MG/M2 IV Q 2 WEEKS. During the same period patient was treated with DOCETAXEL. Patient died on 02/09/2008.

Gemcitabine Side Effects Report #5449730-3
Gemcitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 10, 2007. Male patient, 67 years of age, weighting 134.5 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: bacterial sepsis, disease progression, intestinal obstruction, obstruction gastric. Gemcitabine dosage: 1000MG/M2 IV BOLUS. During the same period patient was treated with BEVACIZUMAB, ERLOTINIB, AMBIEN, CALCIUM, COMPAZINE, CREON, GLYCOLAX, LIPITOR. Patient was hospitalized. Patient recovered.


Gemcitabine Side Effects Report #5357051-2
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on June 12, 2007. Male patient, 58 years of age, weighting 254.0 lb, was diagnosed with pancreatic carcinoma metastatic, metastases to liver and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: abdominal pain , blood glucose increased, blood potassium decreased, disease progression, hyperbilirubinaemia, liver function test abnormal, obstruction, urinary tract infection . Gemcitabine dosage: unknown. During the same period patient was treated with LAPATINIB. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #5345265-7
Gemcitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on June 01, 2007. Female patient, 51 years of age, weighting 99.00 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: abdominal pain , disease progression, nausea . Gemcitabine dosage: unknown. During the same period patient was treated with LAPATINIB. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #4605200-3
Gemcitabine side effect was reported by a Health Professional from on Mar 10, 2005. Female patient, 77 years of age, weighting 108.0 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: constipation , dehydration, disease progression, nausea . Gemcitabine dosage: 1000 MG/M2 Q WK. During the same period patient was treated with COMPAZINE, SYNTHROID, FOSAMAX, ATENOLOL, ZANTAC, PANOKASE, HERBAL SUPPLEMENTS. Patient died on 03/09/2005.

Gemcitabine Side Effects Report #5092013-4
Gemcitabine side effect was reported by a Health Professional from CANADA on Aug 08, 2006. Male patient, 70 years of age, weighting 141.5 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: abdominal pain , constipation , disease progression, intestinal ischaemia, intestinal perforation, nausea , pneumatosis intestinalis. Gemcitabine dosage: 1800 MG, WEEKLY (1/W), INTRAVENOUS. During the same period patient was treated with RANITIDINE, CENTRUM, ACETAMINOPHEN, LACTULOSE, METOCLOPRAMIDE, MORPHINE, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #5448306-1
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on Sept 06, 2007. Female patient, 67 years of age, weighting 143.3 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: deep vein thrombosis , disease progression, intestinal obstruction, nausea . Gemcitabine dosage: 1000MG/M2 DAYS 1,8,15 IV DRIP. During the same period patient was treated with ERLOTINIB. Patient died on 06/26/2007.


Gemcitabine Side Effects Report #4630335-9
Gemcitabine side effect was reported by a Health Professional from on Apr 05, 2005. Male patient, 59 years of age, weighting 139.0 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: abdominal pain , colitis, disease progression. Gemcitabine dosage: 650 MG/M2/WK/IV. During the same period patient was treated with CELEBREX, ARANSP PEN. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #5809642-X
Gemcitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on July 11, 2008. Male patient, 54 years of age, weighting 158.0 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, disease progression, unresponsive to stimuli. Gemcitabine dosage: 1000MG/M2, IV ON D1,8,15. During the same period patient was treated with OXALIPLATIN, NEXIUM, ATIVAN, OXYCODONE, OXYCONTIN, COMPAZINE. Patient died on 05/16/2008.

Gemcitabine Side Effects Report #5154732-0
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on Nov 15, 2006. Male patient, weighting 177.0 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: disease progression, gastric varices haemorrhage, gastritis erosive, haematemesis, haematocrit decreased, haemoglobin decreased, varices oesophageal. Gemcitabine dosage: 1000MG/M2 EVERY OTHER WEEK. During the same period patient was treated with CISPLATIN BM, BEVACIZUMAB. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #5476788-8
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on Oct 03, 2007. Male patient, weighting 200.0 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: ascites, blood creatinine abnormal, disease progression, dyspnoea, fatigue, left ventricular dysfunction, pain . Gemcitabine dosage: 1GM/M2 - 2100 MG WKLY X 3 IV. During the same period patient was treated with LAPATINIB. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #5986032-0
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on Dec 05, 2008. Male patient, weighting 180.3 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: back pain , blood pressure systolic increased, cardiac failure congestive, disease progression, haemoglobin decreased, hypertension, muscle spasms, nausea . Gemcitabine dosage: 1000 MG/M2 DAY 1, DAY 15 IV DRIP. During the same period patient was treated with BEVACIZUMAB GENENTECH, AMLODEPINE, HYDRALAZINE, CLONIDINE, LEVOTHYROXINE, FUROSENIDE, ENOXAPARIN, SKELAXIN. Patient was hospitalized. Patient recovered.


Gemcitabine Side Effects Report #4553750-0
Gemcitabine side effect was reported by a Health Professional from on Jan 14, 2005. Female patient, weighting 177.0 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: disease progression. Gemcitabine dosage: 1000MG.M2 WEEKLY X 6 INTRAVENOUS ; 1000MGM2 Q WKS3,TWK INTRAVENOUS. During the same period patient was treated with ANZEMET, ARANESP. Patient died on 12/10/2004.

Gemcitabine Side Effects Report #4622708-5
Gemcitabine side effect was reported by a Health Professional from on Mar 29, 2005. Female patient, weighting 117.0 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: disease progression, intestinal perforation. Gemcitabine dosage: 1000MG/M2 DAY 1 + 15 INTRAVENOUS. During the same period patient was treated with CISPLATIN, BEVACIZUMAB. Patient died on 03/26/2005.

Gemcitabine Side Effects Report #4698912-7
Gemcitabine side effect was reported by a Consumer or non-health professional from on June 22, 2005. Male patient, weighting 175.3 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: abasia, asthenia, bronchitis , decreased appetite, depressed level of consciousness, disease progression, hepatic lesion, lethargy, rhonchi. Gemcitabine dosage: 1,000MG/M2 IV DAYS 1,8,15 AND 22 ON CYCLE 1 AND DAYS 1,8,15 OF ALL SUBSEQUENT CYCLES.. Patient died on 05/14/2005.

Gemcitabine Side Effects Report #4740363-0
Gemcitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 09, 2005. Male patient, weighting 234.4 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: disease progression, gastrointestinal haemorrhage, haematemesis, hyperhidrosis, lymphadenopathy, melaena, metastatic neoplasm, mucosal ulceration. Gemcitabine dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient died.

Gemcitabine Side Effects Report #4754213-X
Gemcitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 25, 2005. Male patient, weighting 173.3 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: disease progression. Gemcitabine dosage: unknown. Patient was hospitalized. Patient died on 08/01/2005.


Gemcitabine Side Effects Report #4793881-3
Gemcitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 07, 2005. Male patient, weighting 138.7 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: disease progression. Gemcitabine dosage: unknown. Patient died on 07/27/2005.

Gemcitabine Side Effects Report #4818519-8
Gemcitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 01, 2005. Female patient, weighting 123.7 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: asthenia, disease progression, thrombocytopenia. Gemcitabine dosage: unknown. Patient died on 10/19/2005.

Gemcitabine Side Effects Report #4837772-8
Gemcitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 23, 2005. Male patient, weighting 348.3 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: computerised tomogram abnormal, disease progression, lung neoplasm, pulmonary embolism . Gemcitabine dosage: unknown. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #4847101-1
Gemcitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 06, 2005. Female patient, weighting 125.2 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: disease progression. Gemcitabine dosage: unknown. Patient was hospitalized. Patient died on 12/01/2005.

Gemcitabine Side Effects Report #4854435-3
Gemcitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 14, 2005. Male patient, weighting 125.7 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: disease progression, pancreatic carcinoma. Gemcitabine dosage: unknown. Patient died on 06/02/2005.


Gemcitabine Side Effects Report #4863310-X
Gemcitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 19, 2005. Male patient, weighting 190.7 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: disease progression. Gemcitabine dosage: unknown. Patient died on 06/17/2005.

Gemcitabine Side Effects Report #4868110-2
Gemcitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 27, 2005. Female patient, weighting 238.1 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: abasia, abdominal mass, adrenal mass, asthenia, collapse of lung, colonic fistula, disease progression, dysstasia, hepatic mass. Gemcitabine dosage: unknown. Patient was hospitalized. Patient died on 12/12/2005.

Gemcitabine Side Effects Report #5174377-6
Gemcitabine side effect was reported by a Physician from FRANCE on Dec 04, 2006. Female patient, 68 years of age, was diagnosed with ovarian cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: disease progression, pulmonary oedema, thrombotic microangiopathy. Gemcitabine dosage: unknown. Patient died.

Gemcitabine Side Effects Report #5176734-0
Gemcitabine side effect was reported by a Physician from FRANCE on Dec 04, 2006. Female patient, 68 years of age, was diagnosed with ovarian cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, blood pressure increased, disease progression, haemoglobin decreased, neoplasm progression, pulmonary oedema, thrombotic microangiopathy. Gemcitabine dosage: unknown. Patient died.

Gemcitabine Side Effects Report #5985924-6
Gemcitabine side effect was reported by a Physician from UNITED STATES on Dec 05, 2008. Male patient, 73 years of age, weighting 159.6 lb, was diagnosed with non-small cell lung cancer stage iv and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: disease progression, non-small cell lung cancer. Gemcitabine dosage: 400 MG/M2 Q2 WEEKS IV. During the same period patient was treated with PEMETREXED, BEVACIZUMAB, ASPIRIN, SELENIUM, LYCOPENE, VITAMIN B CAP, GLUCOSAMINE, CALCIUM CITRATE. Patient died on 11/25/2008.


Gemcitabine Side Effects Report #5289321-0
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on Apr 04, 2007. Male patient, 60 years of age, weighting 179.0 lb, was diagnosed with non-small cell lung cancer stage iv and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: adenocarcinoma, disease progression, pleural effusion, resuscitation. Gemcitabine dosage: 1970 MG DAYS 3 + 10 Q 21 D IV DRIP. During the same period patient was treated with IMATINIB MESYLATE, ZOLEDRONIC ACID, ONDANSETRON, OXYCONTIN, PREDNISONE, NEURONTIN, AMITRIPTYLINE, LORAZEPAM. Patient died on 04/01/2007.

Gemcitabine Side Effects Report #4738620-7
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on Aug 08, 2005. Female patient, 56 years of age, weighting 197.3 lb, was diagnosed with non-small cell lung cancer stage iv and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea. Gemcitabine dosage: 1000MGM/M2 IV DAY 1 + DAY 8 (2 CYCLES WERE GIVEN). During the same period patient was treated with CARBOPLATIN, MS CONTIN, ALBUTEROL, LORAZEPAM, PROTONIX, LOVENOX. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #5059871-0
Gemcitabine side effect was reported by a Health Professional from NETHERLANDS on June 29, 2006. Male patient, 68 years of age, weighting 3.97 lb, was diagnosed with non-small cell lung cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: campylobacter infection, culture stool positive, disease progression, gastroenteritis , ileus, metastases to liver. Gemcitabine dosage: 2400 MG, Q3W, INTRAVENOUS. During the same period patient was treated with CISPLATIN, DICLOFENAC, ACETAMINOPHEN, ACENOCOUMAROL, FUROSEMIDE, LOSEC. Patient was hospitalized. Patient died on 11/09/2005.

Gemcitabine Side Effects Report #5084493-5
Gemcitabine side effect was reported by a Physician from GERMANY on July 25, 2006. Male patient, 59 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: disease progression, haemoptysis, metastases to liver, metastases to soft tissue, paraproteinaemia. Gemcitabine dosage: unknown. During the same period patient was treated with PACLITAXEL, CISPLATIN, ETOPOSIDE, LORZAAR, BISOPROLOL FUMARATE, CORANGIN. Patient recovered.

Gemcitabine Side Effects Report #5281969-2
Gemcitabine side effect was reported by a Physician from FRANCE on Mar 16, 2007. Male patient, 54 years of age, was diagnosed with non-small cell lung cancer, immunosuppression and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: disease progression, thrombotic microangiopathy. Gemcitabine dosage: unknown. During the same period patient was treated with CARBOPLATIN, CYCLOSPORINE, PREDNISONE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, ANTITHYMOCYTE IMMUNOGLOBULIN, SIROLIMUS. Patient was hospitalized. Patient died on 10/01/2005.


Gemcitabine Side Effects Report #4827667-8
Gemcitabine side effect was reported by a Physician from KOREA, REPUBLIC OF on Nov 04, 2005. Female patient, 44 years of age, weighting 103.6 lb, was diagnosed with non-small cell lung cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, disease progression, metastases to liver. Gemcitabine dosage: 1500 MG/9. During the same period patient was treated with GRANISETRON, WARFARIN. Patient died on 12/09/2004.

Gemcitabine Side Effects Report #4577895-4
Gemcitabine side effect was reported by a Physician from on Jan 21, 2005. Female patient, weighting 141.1 lb, was diagnosed with non-small cell lung cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: cerebral disorder, disease progression, partial seizures. Gemcitabine dosage: unknown. During the same period patient was treated with CISPLATIN, EPILIM, MAGNESIUM OXIDE, DEXAMETHASONE, KYTRIL, DOMPERIDONE. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #4579482-0
Gemcitabine side effect was reported by a Physician from on Feb 01, 2005. Female patient, weighting 141.1 lb, was diagnosed with non-small cell lung cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: disease progression, epistaxis, partial seizures, thrombocytopenia. Gemcitabine dosage: unknown. During the same period patient was treated with CISPLATIN, EPILIM, MAGNESIUM OXIDE, DEXAMETHASONE, KYTRIL, DOMPERIDONE, BENDROFLUAZIDE, ZOLPICLONE. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #4600315-8
Gemcitabine side effect was reported by a Physician from on Feb 15, 2005. Male patient, 54 years of age, weighting 119.0 lb, was diagnosed with neoplasm malignant and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: ascites, coma, disease progression, escherichia bacteraemia, hepatitis b positive, hyperammonaemia, hyperproteinaemia, metabolic acidosis, metastases to liver. Gemcitabine dosage: 1550 MG. During the same period patient was treated with CISPLATIN, LISINOPRIL. Patient was hospitalized. Patient died on 05/01/2002.

Gemcitabine Side Effects Report #4686988-2
Gemcitabine side effect was reported by a Physician from on May 20, 2005. Male patient, 26 years of age, was diagnosed with malignant mediastinal neoplasm and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: disease progression, neurotoxicity, neutropenia, peripheral sensory neuropathy, thrombocytopenia. Gemcitabine dosage: 800 MG/M2 OTHER. During the same period patient was treated with PACLITAXEL, OXALIPLATIN, DEXAMETHASONE, ORPHENADRINE, CIMETIDINE. Patient died.


Gemcitabine Side Effects Report #6058343-4
Gemcitabine side effect was reported by a Physician from UNITED KINGDOM on Jan 16, 2009. Female patient, 38 years of age, was diagnosed with lung cancer metastatic, metastases to liver and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: caesarean section, disease progression, ovarian cyst , pulmonary embolism . Gemcitabine dosage: 1000 MG/M2, DAYS 1 AND 8. During the same period patient was treated with CARBOPLATIN. Patient died.

Gemcitabine Side Effects Report #4667858-2
Gemcitabine side effect was reported by a Physician from on May 20, 2005. Female patient, 45 years of age, weighting 125.0 lb, was diagnosed with leiomyosarcoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: anaemia, blood calcium abnormal, disease progression, hypoalbuminaemia, hypophosphataemia, metastasis, small intestinal obstruction, thrombocytopenia. Gemcitabine dosage: 675 MG/M2 DAYS 1, 8. During the same period patient was treated with DOCETAXEL, AMBIEN, ATIVAN, CELEXA, DARVOCET, DECADRON, FRAGMIN, METHADONE. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #4854268-8
Gemcitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 13, 2005. Female patient, weighting 238.1 lb, was diagnosed with infection , pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: abasia, abdominal mass, adrenal mass, asthenia, collapse of lung, disease progression, dysstasia, hepatic mass, hypoxia. Gemcitabine dosage: unknown. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #5765898-3
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on June 10, 2008. Male patient, 73 years of age, weighting 140.0 lb, was diagnosed with head and neck cancer  and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: disease progression, head and neck cancer . Gemcitabine dosage: 1500 MG/M2 EVERY 14 DAYS IV. During the same period patient was treated with PEMETREXED, SENNA, SYTHROID, MIRALAX, ROXICET, MAGIC MOUTHWASH, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #4816782-0
Gemcitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 31, 2005. Female patient, 57 years of age, weighting 143.3 lb, was diagnosed with endometrial cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: disease progression, hypoventilation, oxygen saturation decreased, pallor, pleural effusion, refusal of treatment by patient, respiratory arrest, somnolence. Gemcitabine dosage: unknown. During the same period patient was treated with DOCETAXEL. Patient died on 07/22/2005.

Gemcitabine Side Effects Report #4564345-7
Gemcitabine side effect was reported by a Physician from on Jan 07, 2005. Female patient, 75 years of age, was diagnosed with diffuse large b-cell lymphoma stage ii and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: acute respiratory failure, disease progression, fluid overload, haematotoxicity, oedema peripheral, rash . Gemcitabine dosage: 1000 MG/M2 OTHER. During the same period patient was treated with RITUXIMAB. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #4618597-5
Gemcitabine side effect was reported by a Physician from on Mar 08, 2005. Female patient was diagnosed with breast cancer metastatic and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: bilirubin conjugated increased, blood bilirubin increased, breast cancer metastatic, coma hepatic, disease progression, jaundice , performance status decreased. Gemcitabine dosage: 1140 MG/2 OTHER. During the same period patient was treated with NAVELBINE. Patient died on 02/16/2005.

Gemcitabine Side Effects Report #4831016-9
Gemcitabine side effect was reported by a Physician from KOREA, REPUBLIC OF on Nov 03, 2005. Female patient, 72 years of age, weighting 147.7 lb, was diagnosed with breast cancer  and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: breast cancer female, disease progression, haemoglobin decreased, neuropathy peripheral, platelet count increased. Gemcitabine dosage: 2000 MG/6 OTHER. Patient recovered.

Gemcitabine Side Effects Report #5550581-X
Gemcitabine side effect was reported by a Physician from JAPAN on Nov 27, 2007. Female patient, weighting 84.22 lb, was diagnosed with bile duct cancer stage iv and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: ascites, disease progression, hepatic function abnormal, hypoalbuminaemia, oedema peripheral, pleural effusion. Gemcitabine dosage: 1130 MG, OTHER. Patient recovered.

Gemcitabine Side Effects Report #5144787-1
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on Nov 03, 2006. Female patient, 61 years of age, weighting 154.4 lb, was diagnosed with bile duct cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: disease progression, jaundice , sepsis . Gemcitabine dosage: unknown. Patient was hospitalized. Patient recovered.


Gemcitabine Side Effects Report #5067897-6
Gemcitabine side effect was reported by a Physician from FRANCE on July 11, 2006. Male patient, 20 years of age, was diagnosed with bile duct cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: abdominal pain , asthenia, coagulopathy, dermatitis acneiform, disease progression, metastases to central nervous system, metastases to lung, musculoskeletal pain. Gemcitabine dosage: 1000 MG/M2, OTHER, INTRAVENOUS. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ERBITUX. Patient died.

Gemcitabine Side Effects Report #4564348-2
Gemcitabine side effect was reported by a Physician from on Jan 07, 2005. Male patient, 78 years of age, was diagnosed with b-cell lymphoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: blood disorder, disease progression, diverticulitis, fluid overload, myocardial infarction, nausea , neutropenia, oedema peripheral. Gemcitabine dosage: 1000 MG/M2 OTHER. During the same period patient was treated with RITUXIMAB, PREDNISONE. Patient was hospitalized. Patient died.

Gemcitabine Side Effects Report #5033639-3
Gemcitabine side effect was reported by a Physician from UNITED STATES on June 15, 2006. Male patient, 66 years of age, was diagnosed with adenocarcinoma pancreas and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: anal fissure, constipation , disease progression, proctitis. Gemcitabine dosage: unknown. During the same period patient was treated with AVASTIN, OXALIPLATIN, ACETAMINOPHEN, GLUCOSAMINE, FOLIC ACID, VITAMIN, MINERAL, ESOMEPRAZOLE MAGNESIUM. Patient was hospitalized. Patient died on 11/23/2005.

Gemcitabine Side Effects Report #4546096-8
Gemcitabine side effect was reported by a Physician from on Dec 13, 2004. Male patient, 58 years of age, weighting 231.5 lb, was diagnosed with adenocarcinoma pancreas and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, blood albumin decreased, capillary leak syndrome, cardiac failure congestive, crepitations, disease progression, dyspnoea, gallop rhythm present. Gemcitabine dosage: unknown. During the same period patient was treated with METFORMIN, STATIN, ANGIOTENSIN. Patient was hospitalized. Patient died.

Gemcitabine Side Effects Report #4889651-8
Gemcitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 20, 2006. Female patient, weighting 125.8 lb, was diagnosed with adenocarcinoma pancreas and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: abdominal pain , disease progression, hepatic cancer metastatic. Gemcitabine dosage: unknown. Patient died on 10/30/2005.

Gemcitabine Side Effects Report #4907626-7
Gemcitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 08, 2006. Male patient, weighting 182.0 lb, was diagnosed with adenocarcinoma pancreas and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: abdominal pain , asthenia, decreased appetite, disease progression, pancreatic carcinoma, small intestinal obstruction, vomiting. Gemcitabine dosage: 2760 MG. Patient was hospitalized. Patient died on 05/22/2005.

Gemcitabine Side Effects Report #4917189-8
Gemcitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 16, 2006. Male patient, weighting 163.1 lb, was diagnosed with adenocarcinoma pancreas and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: disease progression. Gemcitabine dosage: 1425 MG. Patient died on 12/21/2005.

Gemcitabine Side Effects Report #4708367-1
Gemcitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on July 06, 2005. Male patient, weighting 198.4 lb, was diagnosed with adenocarcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: cholangitis, disease progression, sepsis . Gemcitabine dosage: 1000MG/M2 IV DAYS 1, 8. During the same period patient was treated with CAPECITABINE. Patient died.

Gemcitabine Side Effects Report #5084494-7
Gemcitabine side effect was reported by a Consumer or non-health professional from CANADA on July 24, 2006. Male patient, 70 years of age, weighting 141.5 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: chest x-ray abnormal, disease progression, intestinal ischaemia, metastases to the mediastinum, pneumatosis intestinalis. Gemcitabine dosage: 1800 MG, WEEKLY (1/W), INTRAVENOUS. During the same period patient was treated with RANITIDINE, CENTRUM, ACETAMINOPHEN, LACTULOSE, METOCLOPRAMIDE, MORPHINE, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #5049486-2
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on July 11, 2006. Male patient, 54 years of age, was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: blood calcium increased, confusional state, depressed level of consciousness, disease progression, disorientation, infection , oedema peripheral, oxygen saturation decreased, sinusitis . Gemcitabine dosage: unknown. During the same period patient was treated with PACLITAXEL, DEXAMETHASONE, ZOFRAN, BENADRYL. Patient was hospitalized. Patient recovered.


Gemcitabine Side Effects Report #5294527-0
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on Apr 09, 2007. Female patient, weighting 164.9 lb, was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea. Gemcitabine dosage: 1440 MG D1, D8 IV. During the same period patient was treated with CAPECITABINE, NEXIUM, LEXAPRO, PREMARIN, AMARYL, ADVIL, TYLENOL, NORVASC. Patient was hospitalized. Patient died on 04/03/2007.

Gemcitabine Side Effects Report #5387498-X
Gemcitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on July 11, 2007. Male patient, weighting 193.4 lb, was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: anaemia, blood creatine phosphokinase mb increased, chills, disease progression, hallucination, hyperhidrosis, hypotension, hypovolaemia, mesothelioma . Gemcitabine dosage: 2140 MG. During the same period patient was treated with ALIMTA. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #5387679-5
Gemcitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on July 12, 2007. Male patient, weighting 193.4 lb, was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: anaemia, blood creatine phosphokinase mb increased, chills, disease progression, hallucination, hyperhidrosis, hypotension, hypovolaemia, lung infiltration. Gemcitabine dosage: unknown. During the same period patient was treated with ALIMTA. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #4598155-1
Gemcitabine side effect was reported by a Consumer or non-health professional from on Mar 01, 2005. Female patient, weighting 168.7 lb, was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: coagulopathy, disease progression, hepatic failure, pancytopenia, renal failure, respiratory distress, sepsis . Gemcitabine dosage: 1000 MG/M2 IV DAY Q AND DAY 8. During the same period patient was treated with CISPLATIN, ADVAIR DISKUS, ALBUTEROL, LORTAB, MIRALAX. Patient died.

Gemcitabine Side Effects Report #4613479-7
Gemcitabine side effect was reported by a Consumer or non-health professional from on Mar 17, 2005. Female patient, weighting 108.0 lb, was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: constipation , dehydration, disease progression, nausea . Gemcitabine dosage: unknown. Patient was hospitalized. Patient died on 03/09/2005.

Gemcitabine Side Effects Report #4653002-4
Gemcitabine side effect was reported by a Consumer or non-health professional from on May 02, 2005. Male patient, weighting 207.0 lb, was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: bile duct obstruction, dehydration, disease progression, nausea . Gemcitabine dosage: 1000MG/M2 IV WEEKLY. Patient recovered.

Gemcitabine Side Effects Report #4744770-1
Gemcitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 12, 2005. Male patient, weighting 179.2 lb, was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: cardiac disorder, disease progression, dyspnoea, mass. Gemcitabine dosage: unknown. During the same period patient was treated with CAPECITABINE. Patient died on 08/10/2005.

Gemcitabine Side Effects Report #4768268-X
Gemcitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 09, 2005. Male patient, weighting 152.3 lb, was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: disease progression. Gemcitabine dosage: unknown. During the same period patient was treated with CAPECITABINE. Patient died on 05/27/2005.

Gemcitabine Side Effects Report #4808488-9
Gemcitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 21, 2005. Male patient, weighting 129.0 lb, was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: dehydration, disease progression. Gemcitabine dosage: unknown. During the same period patient was treated with CAPECITABINE. Patient died on 06/02/2005.